Optimal Surgery Time After Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancers
Authors:
- Hyo Seong ChoiHCHyo Seong Choi
- Seung-Yong JeongSJSeung-Yong Jeong
- Dae Yong KimDKDae Yong Kim
- Kyung Hae JungKJKyung Hae Jung
- Yong Sang HongYHYong Sang Hong
- Hee Jin ChangHCHee Jin Chang
- Jae-Gahb ParkJPJae-Gahb Park
- 1 August 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 248 (2) , 243-251
Abstract
To evaluate the effect of the time interval between chemoradiotherapy (CRT) and surgery on CRT response and surgical outcomes. Although preoperative CRT is a standard component of multimodal treatment for locally advanced rectal cancers, the optimal time for surgery after CRT has yet to be established. This study analyzed outcomes in 397 prospectively enrolled patients with locally advanced rectal cancer who underwent fractionated CRT involving 50.4 Gy radiotherapy followed by surgical resection between 4 and 8 weeks later. Patients were divided into 2 groups according to the time that elapsed between CRT and surgery: group A (28-41 day interval) and group B (42-56 day interval). CRT responses and surgical outcomes were analyzed. Of the 397 patients, 217 (54.7%) were in group A and 180 (45.3%) in group B. The 2 groups were similar in terms of pretreatment characteristics other than a slight difference in mean age (A: 55.3 years vs. B: 57.5 years, P = 0.042). Analysis of CRT responses showed that the 2 groups were similar in terms of T-level downstaging rate (A: 47.5% vs. B: 44.4%, P = 0.548), volume reduction rate (A: 34.6% vs. B: 34.2%, P = 0.870) and complete response rate (A: 13.8% vs. B: 15.0%, P = 0.740). Analysis of surgical outcomes showed that the 2 groups were also similar in terms of sphincter-preservation rate (A: 83.9% vs. B: 82.2%, P = 0.688) and anastomosis-related complication rate (A: 5.5% vs. B: 3.9%, P = 0.453). The median follow-up period was 31 months (range, 5-63), and both groups showed similar local recurrence-free survival rates (P = 0.1165). The present findings suggest that compared with a 4 to 6 week interval, delaying surgery for 6 to 8 weeks after completion of fractionated radiotherapy with concurrent chemotherapy does not improve CRT response or the sphincter-preservation rate, and does not decrease morbidity or local recurrence.Keywords
This publication has 41 references indexed in Scilit:
- Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3cm of the anal vergeEuropean Journal of Surgical Oncology, 2006
- Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal CancerJournal of Clinical Oncology, 2005
- Swedish Rectal Cancer Trial: Long Lasting Benefits From Radiotherapy on Survival and Local Recurrence RateJournal of Clinical Oncology, 2005
- Preoperative versus Postoperative Chemoradiotherapy for Rectal CancerNew England Journal of Medicine, 2004
- Long-Term Prognostic Significance of Extent of Rectal Cancer Response to Preoperative Radiation and ChemotherapyAnnals of Surgery, 2002
- Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trialsThe Lancet, 2001
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal CancerNew England Journal of Medicine, 2001
- Improved Survival with Preoperative Radiotherapy in Resectable Rectal CancerNew England Journal of Medicine, 1997
- Total mesorectal excision is optimal surgery for rectal cancer: A Scandinavian consensusBritish Journal of Surgery, 1995
- Mesorectal excision for rectal cancerThe Lancet, 1993